HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katsuji Oguchi Selected Research

linoleic acid hydroperoxide

2/2007Effect of a dihydrobenzofuran derivative on lipid hydroperoxide-induced rabbit corneal neovascularization.
4/2006Activation of AP-1 and increased synthesis of MMP-9 in the rabbit retina induced by lipid hydroperoxide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katsuji Oguchi Research Topics

Disease

4Malignant Hyperthermia
01/2020 - 02/2002
4Liver Diseases (Liver Disease)
06/2015 - 10/2005
3Neoplasms (Cancer)
01/2017 - 11/2012
3Glioblastoma (Glioblastoma Multiforme)
10/2015 - 11/2012
3Type 2 Diabetes Mellitus (MODY)
04/2014 - 01/2003
3Body Weight (Weight, Body)
04/2014 - 01/2005
3Atherosclerosis
10/2013 - 01/2003
2Central Core Myopathy (Central Core Disease)
11/2016 - 01/2015
2Triple Negative Breast Neoplasms
04/2016 - 09/2014
2Hypoglycemia (Reactive Hypoglycemia)
06/2015 - 04/2014
2Inflammation (Inflammations)
04/2014 - 01/2005
2Migraine Disorders (Migraine)
04/2012 - 01/2010
2Chronic Kidney Failure (Chronic Renal Failure)
09/2005 - 01/2005
1Osteoporosis
01/2017
1Stable Angina
06/2016
1AIDS-Related Complex (ARC)
05/2016
1Pathologic Constriction (Stenosis)
05/2016
1Brain Neoplasms (Brain Tumor)
10/2015
1Dementia (Dementias)
06/2015
1Diabetic Retinopathy (Retinopathy, Diabetic)
06/2015
1Breast Neoplasms (Breast Cancer)
09/2014
1Neuroblastoma
02/2014
1Reperfusion Injury
02/2014
1Adenocarcinoma
09/2013
1Carcinogenesis
06/2013
1Exanthema (Rash)
01/2013
1Migraine with Aura (Familial Hemiplegic Migraine)
01/2010
1Epilepsy (Aura)
01/2010
1Anodontia (Hypodontia)
12/2008
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2007
1Autoimmune Diseases (Autoimmune Disease)
08/2007
1Disease Progression
08/2007
1Corneal Neovascularization
02/2007
1Mitochondrial Diseases (Mitochondrial Disease)
10/2006
1Retinal Neovascularization
04/2006
1Colitis
01/2005

Drug/Important Bio-Agent (IBA)

4Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2020 - 02/2002
3Hemoglobins (Hemoglobin)IBA
04/2014 - 01/2005
3Proteins (Proteins, Gene)FDA Link
02/2014 - 11/2012
2Pharmaceutical PreparationsIBA
01/2017 - 01/2013
2CalciumIBA
06/2016 - 05/2016
2Insulin (Novolin)FDA Link
06/2015 - 01/2013
2CholesterolIBA
04/2014 - 01/2013
2Blood Glucose (Blood Sugar)IBA
04/2014 - 01/2013
2AlbuminsIBA
04/2014 - 01/2013
2Sucrose (Saccharose)IBA
10/2013 - 10/2007
2SolutionsIBA
10/2013 - 10/2007
2Bile Acids and Salts (Bile Acids)IBA
11/2007 - 10/2006
2linoleic acid hydroperoxideIBA
02/2007 - 04/2006
2Messenger RNA (mRNA)IBA
01/2005 - 01/2005
2Fibrinogen (Factor I)FDA Link
01/2005 - 01/2003
1Monoclonal AntibodiesIBA
01/2017
1LigandsIBA
01/2017
1DenosumabFDA Link
01/2017
1Hormones (Hormone)IBA
04/2016
1eribulinFDA Link
04/2016
1Dipeptidyl-Peptidase IV InhibitorsIBA
06/2015
1GemcitabineFDA Link
09/2014
1Poly (ADP-Ribose) Polymerase-1IBA
09/2014
1LinagliptinIBA
04/2014
1LDL CholesterolIBA
04/2014
1C-Reactive ProteinIBA
04/2014
1Propofol (Diprivan)FDA LinkGeneric
02/2014
1Neuroprotective AgentsIBA
02/2014
1ThapsigarginIBA
02/2014
1Ethanol (Ethyl Alcohol)IBA
09/2013
1Benzoates (Benzoate)IBA
01/2013
1alogliptinIBA
01/2013
1C-PeptideIBA
01/2013
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2013
1Glucagon (Glukagon)FDA Link
01/2013
1MicroRNAs (MicroRNA)IBA
11/2012
1Monoamine Oxidase (MAO)IBA
04/2012
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
04/2012
1Lymphotoxin-alpha (Lymphotoxin)IBA
04/2012
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
01/2010
1Serotonin (5 Hydroxytryptamine)IBA
01/2010
1diphenylthiosulfinate (DPTS)IBA
12/2008
1Glycochenodeoxycholic Acid (Glycochenodeoxycholate)IBA
11/2007
1Pioglitazone (Actos)FDA Link
10/2007
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
10/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2007
1CytokinesIBA
08/2007
1Lipid PeroxidesIBA
02/2007
1A-3922IBA
02/2007
1Death Domain ReceptorsIBA
10/2006
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
04/2006
1Matrix Metalloproteinases (MMPs)IBA
04/2006
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
10/2005
1Superoxide Dismutase-1IBA
09/2005
1nobiletinIBA
01/2005
1Sulfonic AcidsIBA
01/2005

Therapy/Procedure

3Therapeutics
09/2014 - 08/2007
3Renal Dialysis (Hemodialysis)
04/2014 - 09/2005
2Drug Therapy (Chemotherapy)
10/2015 - 06/2013
2Aftercare (After-Treatment)
04/2014 - 01/2013
1Percutaneous Coronary Intervention
06/2016
1Injections
06/2015
1Glycemic Control
04/2014
1Radiotherapy
06/2013